• Zamawiaj do paczkomatu
  • Płać wygodnie
  • Obniżka
Advances in Oncology, 2022

Advances in Oncology, 2022

9780323986694
PRINT ON DEMAND - DELIVERY CAN TAKE UP TO 14 DAYS
881,95 zł
749,66 zł Zniżka 132,29 zł Brutto
Najniższa cena w okresie 30 dni przed promocją: 749,66 zł
Ilość
Od 4 do 6 tygodni

  Dostawa

Wybierz Paczkomat Inpost, Orlen Paczkę, DPD, Pocztę, email (dla ebooków). Kliknij po więcej

  Płatność

Zapłać szybkim przelewem, kartą płatniczą lub za pobraniem. Kliknij po więcej szczegółów

  Zwroty

Jeżeli jesteś konsumentem możesz zwrócić towar w ciągu 14 dni*. Kliknij po więcej szczegółów

Opis
Advances in Oncology reviews the years most important findings and updates within the cancer field for the practicing oncologist. A distinguished editorial board, led by Dr. Leonidas C. Platanias, identifies key areas of major progress and controversy and invites preeminent specialists to contribute original articles devoted to these topics. These insightful overviews in oncology inform and enhance clinical practice by  bringing concepts to a clinical level and exploring their everyday impact on patient care.
Szczegóły produktu
Elsevier
92158
9780323986694
9780323986694

Opis

Rok wydania
2022
Numer wydania
1
Oprawa
twarda
Liczba stron
240
Waga (g)
750
  • Neoadjuvant Chemotherapy for Nonmetastatic Breast Cancer: How Response Impacts Locoregional and Adjuvant Systemic Therapy Decision Making
    Contemporary Multimodal Management of Primary Retroperitoneal Sarcomas
    NTRK Inhibitors in Adult Patients with Solid Tumors
    The Landscape of Personalized Medicine in Gynecologic Cancer
    Geriatric Assessments: Tools for Every Oncologist to Stage the Aging When Caring for Older Adults with Cancer
    Sentinel Lymph Node Sampling in Endometrial Cancers
    Health Care Disparities in Gynecologic Oncology
    Clinical Trials of Oncolytic Viruses in Glioblastoma
    Circulating Tumor Cells and Cell-free Tumor DNA in Evaluation and Management of Gliomas: Current Evidence and Potential Future Clinical Use
    Optimizing Hematopoietic Cellular Transplantation in Older Adults with Hematologic Malignancies
    Moving Toward a Cure in Multiple Myeloma:Eradication of Measurable Residual Disease
    Advances in Janus-Associated Kinase Inhibitor-Based Therapies for Philadelphia Chromosome-Negative Myeloproliferative Neoplasms
    Deoxyribonucleic Acid Damage Response Defects: Clinical Implications and the Role of Poly-ADP Ribose Polymerase Inhibitors in Genitourinary Cancers and Beyond
    Clinical Trial Considerations for Bladder Preservation in Muscle-Invasive Bladder Cancer
    The Changing Demographics of Colorectal Cancer: Rising Incidence in Younger Individuals
    Total Neoadjuvant Strategies for Locally Advanced Rectal Cancer
Komentarze (0)